Co-sponsors propose at least three year patent waiver for covid drugs, vaccines
- The patent waiver proposal spearheaded by India and South Africa received a boost from 62 co-sponsors that have proposed the temporary waiver to be in place for at least three years, given the uncertainty regarding vaccine effectiveness for children and against new variants